Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare and life-threatening complication that can occur after COVID-19 vaccination. After the first reports of VITT and CVST in 2021 after Ad26.COV2.S vaccination, the FDA and CDC recommended an emergency pause on 13 April 2021, and after...
Main Authors: | James Fan Wu, Umair Bajwa, Muhammad Hammad |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-07-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2022.2071854 |
Similar Items
-
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
by: Archrob Khuhapinant, et al.
Published: (2021-09-01) -
Cerebral Venous Sinus Thrombosis Associated with Vaccine-Induced Thrombotic Thrombocytopenia—A Narrative Review
by: Adrian Scutelnic, et al.
Published: (2022-04-01) -
Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
by: Young Shil Park
Published: (2021-08-01) -
Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review
by: Wei Lin, et al.
Published: (2021-09-01) -
Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT)
by: Nancy Yomayusa
Published: (2021-08-01)